找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Glaucoma Drainage Devices; A Practical Illustra Monica Gandhi,Shibal Bhartiya Book 2019 Springer Nature Singapore Pte Ltd. 2019 Surgical te

[復(fù)制鏈接]
樓主: OAK
31#
發(fā)表于 2025-3-26 23:41:19 | 只看該作者
32#
發(fā)表于 2025-3-27 04:10:28 | 只看該作者
33#
發(fā)表于 2025-3-27 08:15:49 | 只看該作者
34#
發(fā)表于 2025-3-27 11:10:05 | 只看該作者
https://doi.org/10.1007/978-3-662-48417-3tained on maximally tolerable medical therapy and glaucomatous damage is still progressing or is deemed likely to progress, then surgery is suggested to the patient. Usually, the surgeon and the patient are faced with a dilemma to choose between a trabeculectomy and a glaucoma drainage device.
35#
發(fā)表于 2025-3-27 14:29:55 | 只看該作者
36#
發(fā)表于 2025-3-27 21:02:59 | 只看該作者
https://doi.org/10.1007/978-3-662-12009-5irreversible blindness. Therefore management of IOP may be required before, along with or after the patient has undergone PKP. Irreversible visual loss is seen due to optic nerve damage, and graft failure is caused by persistent rise in IOP leading to chronic corneal endothelial damage leading to corneal oedema and compromised graft clarity [1].
37#
發(fā)表于 2025-3-27 22:06:08 | 只看該作者
Ettore Majorana International Science Seriesprimary surgery of choice in refractory glaucomas like post-penetrating keratoplasty glaucoma, glaucoma following retinal surgery, neovascular glaucoma, and irido-corneal endothelial syndrome and in patients with scarred conjunctiva. They are frequently used in cases with failed trabeculectomy surgery also.
38#
發(fā)表于 2025-3-28 05:58:08 | 只看該作者
Preparing the Patient for the Glaucoma Drainage Device Surgery,tained on maximally tolerable medical therapy and glaucomatous damage is still progressing or is deemed likely to progress, then surgery is suggested to the patient. Usually, the surgeon and the patient are faced with a dilemma to choose between a trabeculectomy and a glaucoma drainage device.
39#
發(fā)表于 2025-3-28 08:10:13 | 只看該作者
40#
發(fā)表于 2025-3-28 10:45:29 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 03:11
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
玛多县| 寿宁县| 金阳县| 宁海县| 富阳市| 南部县| 通榆县| 武定县| 高陵县| 读书| 法库县| 庆云县| 厦门市| 台中市| 清流县| 林西县| 高平市| 郎溪县| 阳新县| 南安市| 安塞县| 志丹县| 西林县| 兰州市| 建宁县| 辉南县| 汨罗市| 汶上县| 潞西市| 文安县| 来凤县| 贵南县| 靖宇县| 化隆| 东光县| 当涂县| 南乐县| 博罗县| 惠州市| 沁阳市| 新化县|